Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer.
In a notice posted to the Food and Drug Administration’s (FDA) website on Thursday, Pfizer said it was recalling Chantix 0.5 mg and 1 mg tablets to the consumer level due to the presence of N-nitroso-varenicline.
Long term ingestion of N-nitroso-varenicline can be associated with a “theoretical potential increased cancer risk in humans,” the notice said. However, there is no immediate risk to patients taking the drug.
The company said it is undertaking the recall as a precautionary measure, adding that the benefits of stopping smoking “outweigh the theoretical potential cancer risk from the nitrosamine impurity."
Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer | TheHill
Chantix was approved by the FDA in 2006.
Drug Approval Package: Chantix (Varenicline) NDA #021928 (fda.gov)
A mere 14 years later, they're recalling it due to the fact that it causes cancer.
Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content | FDA
Remember, the benefits outweigh the risk! (but we're still recalling it...)
In a notice posted to the Food and Drug Administration’s (FDA) website on Thursday, Pfizer said it was recalling Chantix 0.5 mg and 1 mg tablets to the consumer level due to the presence of N-nitroso-varenicline.
Long term ingestion of N-nitroso-varenicline can be associated with a “theoretical potential increased cancer risk in humans,” the notice said. However, there is no immediate risk to patients taking the drug.
The company said it is undertaking the recall as a precautionary measure, adding that the benefits of stopping smoking “outweigh the theoretical potential cancer risk from the nitrosamine impurity."
Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer | TheHill
Chantix was approved by the FDA in 2006.
Drug Approval Package: Chantix (Varenicline) NDA #021928 (fda.gov)
A mere 14 years later, they're recalling it due to the fact that it causes cancer.
Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content | FDA
Remember, the benefits outweigh the risk! (but we're still recalling it...)